Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

News | Atrial Fibrillation | Dave Fornell, Editor

May 14, 2019 – The first prospective, multicenter, randomized, controlled trial to compare conventional pulmonary vein ...

Home May 14, 2019
Home
News | Atrial Fibrillation

May 13, 2019 — A randomized clinical trial effectively used nerve stimulation through an ear clip to reduce atrial ...

Home May 13, 2019
Home
News | Atrial Fibrillation

May 13, 2019 — A digital screening for atrial fibrillation (AFib or AF) successfully monitored more than 60,000 ...

Home May 13, 2019
Home
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.
Feature | Dave Fornell, Editor

May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has ...

Home May 10, 2019
Home
News | EP Mapping and Imaging Systems

May 9, 2019 — Philips announced a collaboration with Medtronic to further advance treatment of paroxysmal atrial ...

Home May 09, 2019
Home
News

May 8, 2019 — Even though many medical practitioners may opt not to perform procedures on higher-risk patients, new ...

Home May 08, 2019
Home
News

April 16, 2019 — CardioFocus Inc. announced the European CE Mark approval of the HeartLight X3 Endoscopic Ablation ...

Home April 16, 2019
Home
Videos | Wearables

Khaldoun Tarakji, M.D., MPH, staff physician in the Section of Electrophysiology and Pacing in the Robert and Suzanne ...

Home March 26, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

March 19, 2019 — The Bristol-Myers Squibb-Pfizer Alliance announced results from the Phase 4 AUGUSTUS trial evaluating ...

Home March 19, 2019
Home
Feature | ACC

The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.19 ...

Home March 19, 2019
Home
News | Wearables

March 18, 2019 — Researchers from the Stanford University School of Medicine presented preliminary results of the Apple ...

Home March 18, 2019
Home
News

February 4, 2019 – Biosense Webster has enrolled and treated the first patient in its U.S. Investigational Device ...

Home February 04, 2019
Home
Rivaroxaban is among four new oral anticoagulants (NOAC) now recommended by atrial fibrillation guidelines over the old standard of warfarin.
Feature | Atrial Fibrillation
January 30, 2019 — Updated atrial fibrillation (AFib) treatment guidelines released this week now recommend new oral ...
Home January 30, 2019
Home
Subscribe Now